ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
GlaxoSmithKline AG - Havrix 720, Injektionssuspension
0059901
Havrix 720Injektionssuspension
J07BC02Hepatitis A, Inactivated, Whole Virus
30.09.1996  
Composition
Vaccinum adsorbatum: hepatitis-A-virus inactivatus (HM175) 720 U. corresp. proteina max. 0.2 µg, aluminii hydroxidum hydricum ad adsorptionem corresp. aluminium 0.25 mg, aminoacida cum phenylalaninum 83 µg, dinatrii phosphas, kalii dihydrogenophosphas, natrii chloridum, kalii chloridum, polysorbatum 20, aqua ad iniectabile, ad suspensionem pro 0.5 ml corresp. natrium max. 1.7 mg et kalium max. 0.2 mg, residui: neomycini sulfas.
Packungsbestandteile
Injection suspension
 
 
Active AgentDoseadditional_information
Hepatitis-A-Virus Inactivatus (Hm175)720U. / 0.5ml correspond Protein 0.2µg / 0.5mlVaccinum adsorbatum
 
Inactive agentsDose
Aluminii Hydroxidum Hydricum ad Adsorptionem 
Aminoacida cum Phenylalaninum83µg / 0.5ml
Disodium Phosphate 
Potassium Chloride 
Potassium Dihydrogenophosphate 
Sodium Chloride 
Polysorbatum 20 
Package numberPackage SizeEFPCPCategorySLOut of trade (MedRef)
002 PRPRB No
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home